In the last trading session, 1.04 million BioAge Labs Inc (NASDAQ:BIOA) shares changed hands as the company’s beta touched 0. With the company’s per share price at $5.94 changed hands at -$0.2 or -3.26% during last session, the market valuation stood at $212.95M. BIOA’s last price was a discount, traded about -348.15% off its 52-week high of $26.62. The share price had its 52-week low at $3.85, which suggests the last value was 35.19% up since then. When we look at BioAge Labs Inc’s average trading volume, we note the 10-day average is 2.94 million shares, with the 3-month average coming to 832.11K.

BioAge Labs Inc (NASDAQ:BIOA) trade information

Instantly BIOA was in red as seen at the end of in last trading. With action 43.48%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -67.56%, with the 5-day performance at 43.48% in the green. However, in the 30-day time frame, BioAge Labs Inc (NASDAQ:BIOA) is -67.79% down. Looking at the short shares, we see there were 2.37 million shares sold at short interest cover period of 11.43 days.

The consensus price target for the stock as assigned by Wall Street analysts is 40, meaning bulls need an upside of 85.15% from its current market value. According to analyst projections, BIOA’s forecast low is 7 with 45 as the target high. To hit the forecast high, the stock’s price needs a -657.58% plunge from its current level, while the stock would need to soar -17.85% for it to hit the projected low.

BIOA Dividends

BioAge Labs Inc is expected to release its next quarterly earnings report in January.